- Home
- PRGO
PRGO
Perrigo Company plc
as of 03-06-2026 3:55pm EST
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
| Founded: | 1887 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN 2 |
| Market Cap: | 2.0B | IPO Year: | 2013 |
| Target Price: | $19.33 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | -10.29 | EPS Growth: | -723.20 |
| 52 Week Low/High: | $11.13 - $29.08 | Next Earning Date: | 05-29-2026 |
| Revenue: | $800,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 0.02% | Revenue Growth (next year): | 1.36% |
| P/E Ratio: | -1.08 | Index: | N/A |
| Free Cash Flow: | 145.1M | FCF Growth: | -37.92% |
AI-Powered PRGO Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K HOLD Feb 26, 2026 · 1% conf.
Q4 2025 Earnings
8-K HOLDFeb 26, 2026 · 1% conf.
1D
+2.57%
$14.56
Act: -6.91%
5D
+2.51%
$14.55
Act: -21.07%
20D
+1.60%
$14.42
prgo-202602260001585364false00015853642026-02-262026-02-260001585364prgo:OrdinaryShares0001ParValueMember2026-02-262026-02-260001585364prgo:A4.900SeniorNotesDueJune152030Member2026-02-262026-02-260001585364prgo:A6.125SeniorNotesDue2032Member2026-02-262026-02-260001585364prgo:A5.375SeniorNotesDue2032Member2026-02-262026-02-260001585364prgo:A5.30UnsecuredSeniorNotesDueNovember152043Member2026-02-262026-02-260001585364prgo:A49SeniorLoanDue2024Member2026-02-262026-02-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 26, 2026
Perrigo Company plc
(Exact name of registrant as specified in its charter)
Commission file number 001-36353
Ireland Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74 +353 1 7094000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities Registered pursuant to section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Ordinary shares, €0.001 par valuePRGONew York Stock Exchange 4.900% Notes due 2030 PRGO30New York Stock Exchange 6.125% Notes due 2032
PRGO32A
New York Stock Exchange 5.375% Notes due 2032
PRGO32B
New York Stock Exchange 5.300% Notes due 2043PRGO43New York Stock Exchange 4.900% Notes due 2044PRGO44New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02. Results of Operations and Financial Condition
On February 26, 2026, Perrigo Company plc (the “Company”) released earnings for the fourth quarter ended December 31, 2025. The press release related to the Company’s earnings is attached as Exhibit 99.1.
The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and, where applicable, with companies in similar industries and assessing the Company's prospects for future performance. These non-GAAP financial measures exclude items, such as amortization expense, unusual litigation, impairment charges, restructuring charges, and acquisition and integration-related charges, that by their nature affect comparability of operational performance or that we believe obscure underlying business operational trends. The intangible asset amortization excluded from these non-GAAP financial measures represents the entire amount recorded within the Company’s GAAP financial statements and is excluded because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised. The revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. The non-GAAP measures the Company provides are consistent with how management analyzes and assesses the operating performance of the Company, and disclosing them provides investor insight into management’s view of the business. Management uses these adjusted financial measures for planning and forecasting in future periods, and evaluating segment and overall operating performance. In addition, management uses certain of the profit measures as factors in determining compensation.
Non-GAAP measures re
2025 Q3 Q3 2025 Earnings
8-K Nov 5, 2025
Q3 2025 Earnings
8-KNov 5, 2025
prgo-202511050001585364false00015853642025-11-052025-11-050001585364prgo:OrdinaryShares0001ParValueMember2025-11-052025-11-050001585364prgo:A4.900SeniorNotesDueJune152030Member2025-11-052025-11-050001585364prgo:A6.125SeniorNotesDue2032Member2025-11-052025-11-050001585364prgo:A5.375SeniorNotesDue2032Member2025-11-052025-11-050001585364prgo:A5.30UnsecuredSeniorNotesDueNovember152043Member2025-11-052025-11-050001585364prgo:A49SeniorLoanDue2024Member2025-11-052025-11-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 5, 2025
Perrigo Company plc
(Exact name of registrant as specified in its charter)
Commission file number 001-36353
Ireland Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74 +353 1 7094000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities Registered pursuant to section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Ordinary shares, €0.001 par valuePRGONew York Stock Exchange 4.900% Notes due 2030 PRGO30New York Stock Exchange 6.125% Notes due 2032
PRGO32A
New York Stock Exchange 5.375% Notes due 2032
PRGO32B
New York Stock Exchange 5.300% Notes due 2043PRGO43New York Stock Exchange 4.900% Notes due 2044PRGO44New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02. Results of Operations and Financial Condition
On November 5, 2025, Perrigo Company plc (the “Company”) released earnings for the third quarter ended September 27, 2025. The press release related to the Company’s earnings is attached as Exhibit 99.1.
The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and, where applicable, with companies in similar industries and assessing the Company's prospects for future performance. These non-GAAP financial measures exclude items, such as amortization expense, unusual litigation, impairment charges, restructuring charges, and acquisition and integration-related charges, that by their nature affect comparability of operational performance or that we believe obscure underlying business operational trends. The intangible asset amortization excluded from these non-GAAP financial measures represents the entire amount recorded within the Company’s GAAP financial statements and is excluded because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised. The revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. The non-GAAP measures the Company provides are consistent with how management analyzes and assesses the operating performance of the Company, and disclosing them provides investor insight into management’s view of the business. Management uses these adjusted financial measures for planning and forecasting in future periods, and evaluating segment and overall operating performance. In addition, management uses certain of the profit measures as factors in determining compensation.
Non-GAAP measures rela
2025 Q2 Q2 2025 Earnings
8-K Aug 6, 2025
Q2 2025 Earnings
8-KAug 6, 2025
prgo-202508060001585364false00015853642025-08-062025-08-060001585364prgo:OrdinaryShares0001ParValueMember2025-08-062025-08-060001585364prgo:A4.900SeniorNotesDueJune152030Member2025-08-062025-08-060001585364prgo:A6.125SeniorNotesDue2032Member2025-08-062025-08-060001585364prgo:A5.375SeniorNotesDue2032Member2025-08-062025-08-060001585364prgo:A5.30UnsecuredSeniorNotesDueNovember152043Member2025-08-062025-08-060001585364prgo:A49SeniorLoanDue2024Member2025-08-062025-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 6, 2025
Perrigo Company plc
(Exact name of registrant as specified in its charter)
Commission file number 001-36353
Ireland Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74 +353 1 7094000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities Registered pursuant to section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Ordinary shares, €0.001 par valuePRGONew York Stock Exchange 4.900% Notes due 2030 PRGO30New York Stock Exchange 6.125% Notes due 2032
PRGO32A
New York Stock Exchange 5.375% Notes due 2032
PRGO32B
New York Stock Exchange 5.300% Notes due 2043PRGO43New York Stock Exchange 4.900% Notes due 2044PRGO44New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02. Results of Operations and Financial Condition
On August 6, 2025, Perrigo Company plc (the “Company”) released earnings for the second quarter ended June 28, 2025. The press release related to the Company’s earnings is attached as Exhibit 99.1.
The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and, where applicable, with companies in similar industries and assessing the Company's prospects for future performance. These non-GAAP financial measures exclude items, such as amortization expense, unusual litigation, impairment charges, restructuring charges, and acquisition and integration-related charges, that by their nature affect comparability of operational performance or that we believe obscure underlying business operational trends. The intangible asset amortization excluded from these non-GAAP financial measures represents the entire amount recorded within the Company’s GAAP financial statements and is excluded because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised. The revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. The non-GAAP measures the Company provides are consistent with how management analyzes and assesses the operating performance of the Company, and disclosing them provides investor insight into management’s view of the business. Management uses these adjusted financial measures for planning and forecasting in future periods, and evaluating segment and overall operating performance. In addition, management uses certain of the profit measures as factors in determining compensation.
Non-GAAP measures related to p
Compare PRGO vs Leading Stocks
See how PRGO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PRGO Perrigo Company plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.